Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-115992
Filing Date
2026-03-19
Accepted
2026-03-19 16:15:30
Documents
81
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K asmb-20251231.htm   iXBRL 10-K 3289770
2 EX-23.1 asmb-ex23_1.htm EX-23.1 18799
3 EX-31.1 asmb-ex31_1.htm EX-31.1 17129
4 EX-31.2 asmb-ex31_2.htm EX-31.2 17121
5 EX-32.1 asmb-ex32_1.htm EX-32.1 8643
6 EX-32.2 asmb-ex32_2.htm EX-32.2 8596
  Complete submission text file 0001193125-26-115992.txt   13412007

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20251231.xsd EX-101.SCH 1662244
85 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20251231_htm.xml XML 2744061
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35005 | Film No.: 26774408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)